Seth Jaffe - Mar 25, 2019 Form 4/A - Amendment Insider Report for LEVI STRAUSS & CO (LEVI)

Role
EVP & General Counsel
Signature
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
Stock symbol
LEVI
Transactions as of
Mar 25, 2019
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/21/2023, 06:29 PM
Date Of Original Report
Mar 27, 2019
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEVI Common Stock Other $0 -228K -81.23% $0.00 52.8K Mar 25, 2019 Direct F1
transaction LEVI Common Stock Other $0 -52.8K -100% $0.00* 0 Mar 25, 2019 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEVI Class B Common Stock Other $0 +228K $0.00 228K Mar 25, 2019 Class A Common Stock 228K Direct F1
transaction LEVI Class B Common Stock Other $0 +52.8K +23.11% $0.00 281K Mar 25, 2019 Class A Common Stock 52.8K Direct F1, F2, F3
transaction LEVI Stock Appreciation Rights Other $0 -453K -100% $0.00* 0 Mar 25, 2019 Common Stock 453K $6.10 Direct F1, F4, F5
transaction LEVI Stock Appreciation Rights Other $0 +453K $0.00 453K Mar 25, 2019 Class B Common Stock 453K $6.10 Direct F1, F4, F5
transaction LEVI Stock Appreciation Rights Other $0 -340K -100% $0.00* 0 Mar 25, 2019 Common Stock 340K $7.43 Direct F1, F4, F6
transaction LEVI Stock Appreciation Rights Other $0 +340K $0.00 340K Mar 25, 2019 Class B Common Stock 340K $7.43 Direct F1, F4, F6
transaction LEVI Stock Appreciation Rights Other $0 -280K -100% $0.00* 0 Mar 25, 2019 Common Stock 280K $6.45 Direct F1, F4, F7
transaction LEVI Stock Appreciation Rights Other $0 +280K $0.00 280K Mar 25, 2019 Class B Common Stock 280K $6.45 Direct F1, F4, F7
transaction LEVI Stock Appreciation Rights Other $0 -44.7K -100% $0.00* 0 Mar 25, 2019 Common Stock 44.7K $14.88 Direct F1, F4, F8
transaction LEVI Stock Appreciation Rights Other $0 +44.7K $0.00 44.7K Mar 25, 2019 Class B Common Stock 44.7K $14.88 Direct F1, F4, F8
transaction LEVI Stock Appreciation Rights Other $0 -74.1K -100% $0.00* 0 Mar 25, 2019 Common Stock 74.1K $9.60 Direct F1, F4, F9
transaction LEVI Stock Appreciation Rights Other $0 +74.1K $0.00 74.1K Mar 25, 2019 Class B Common Stock 74.1K $9.60 Direct F1, F4, F9
transaction LEVI Stock Appreciation Rights Other $0 -108K -100% $0.00* 0 Mar 25, 2019 Common Stock 108K $6.90 Direct F1, F4, F10
transaction LEVI Stock Appreciation Rights Other $0 +108K $0.00 108K Mar 25, 2019 Class B Common Stock 108K $6.90 Direct F1, F4, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F2 This Form 4/A is being filed to correct the disclosure relating to RSUs set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. As a result, certain subsequent instances of withholding of shares to satisfy tax liabilities were reported solely within Table I.
F3 Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Of these RSUs, (i) 24,230 RSUs vest on February 1, 2020, (ii) 15,130 RSUs vest in four equal annual installments beginning on January 30, 2019, and (iii) 13,440 RSUs vest in four equal annual installments beginning on January 30, 2020.
F4 Each stock appreciation right (SAR) represents the right to receive, upon exercise, shares of the Issuer's Common Stock (and, after the conversion noted in footnote (1), Class B Common Stock) with a value equal to the increase in the fair market value of one share of such stock from the date of grant of the SAR.
F5 Of these SARs: (i) 206,050 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 247,270 SARs that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.
F6 Of these SARs: (i) 144,430 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 195,180 SARs that are fully vested.
F7 Of these SARs: (i) 93,190 are PSARs that vested on February 1, 2017 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 186,370 SARs that are fully vested.
F8 25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021.
F9 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.
F10 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.